Contents

1. Name 1

2. Commencement 1

3. Authority 1

4. Definitions 1

5. Treatment of relevant services 2

6. Bulk-billing—magnetic resonance imaging 3

7. Application of items 63454 and 63460 3

8. Application of items 63545 and 63546 3

9. Application of contrast 4

Schedule 1 – relevant services 5

Part 1 – MRI obstetric services for suspected fetal central nervous system abnormality 5

Part 2 – MRI services for colorectal or hepatocellular carcinomas 6

Part 3 – Hepatobiliary-specific contrast agent services 7

Endnotes 8

Endnote 1—About the endnotes 8

Endnote 2—Abbreviation key 9

Endnote 3—Legislation history 10

Endnote 4—Amendment history 11

1. Name

This Determination is the Health Insurance (Section 3C Diagnostic Imaging Services – Liver and Obstetric MRI Services) Determination 2019.

2. Commencement

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

<table cellspacing="0" cellpadding="0" style="width:100%; border-collapse:collapse"><thead><tr><td colspan="3" style="border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Commencement information</span></p></td></tr><tr><td style="width:25.44%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Column 1</span></p></td><td style="width:52.54%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Column 2</span></p></td><td style="width:22.02%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Column 3</span></p></td></tr><tr><td style="width:25.44%; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Provisions</span></p></td><td style="width:52.54%; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Commencement</span></p></td><td style="width:22.02%; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Date/Details</span></p></td></tr></thead><tbody><tr><td style="width:25.44%; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:12pt"><span style="font-size:10pt">1.</span><span style="font-size:10pt"> </span><span style="font-size:10pt">The whole of this instrument</span></p></td><td style="width:52.54%; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:12pt"><span style="font-size:10pt">1 </span><span style="font-size:10pt">May</span><span style="font-size:10pt"> 2019</span></p></td><td style="width:22.02%; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top"><p style="margin-top:3pt; line-height:12pt"><span style="font-size:10pt"></span></p></td></tr></tbody></table>

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3. Authority

This Determination is made under subsection 3C(1) of the Health Insurance Act 1973.

4. Definitions

(1) In this Determination:

Act means the Health Insurance Act 1973.

eligible equipment has the meaning given by clause 2.5.5 of the diagnostic imaging services table.

eligible provider has the meaning given by clause 2.5.4 (item 1) of the diagnostic imaging services table.

(K) has the meaning given by subclause 1.2.1(2) of the diagnostic imaging services table.

(NK) has the meaning given by subclause 1.2.1(1) of the diagnostic imaging services table.

partial eligible equipment has the meaning given by clause 2.5.6 of the diagnostic imaging services table.

relevant provisions means all provisions, of the Act and regulations made under the Act, and the National Health Act 1953 and regulations made under that Act, relating to medical services, professional services or items.

relevant service means a health service, as defined in subsection 3C(8) of the Act, that is specified in the Schedule.

remote location has the meaning given by the same term in Part 3 of the diagnostic imaging services table.

scan means a minimum of 3 sequences.

sequence, for a scan, means a series of images collected at the same time with similar image parameters (not including a scan designed to establish patient position and subsequently used to plan other scans).

Schedule means the Schedule to this Determination.

Note: The following terms are defined in subsection 3(1) of the Act:

• clinically relevant service
• consultant physician
• diagnostic imaging services table
• general medical services table
• item
• professional service
• specialist

Note: For the effect of the term (Anaes.) used in items in this table, see subclause 2.44.5(2) of the general medical services table.

(2) Unless the contrary intention appears, a reference in this Determination to a provision of the Act or the National Health Act 1953 or regulations made under the Act or under the National Health Act 1953 as applied, adopted or incorporated in relation to specifying a matter is a reference to those provisions as in force from time to time and any other reference to provisions of an Act or regulations is a reference to those provisions as in force from time to time.

5. Treatment of relevant services

For subsection 3C(1) of the Act a relevant service, provided in accordance with this Determination and as a clinically relevant service, is to be treated, for the relevant provisions, as if:

(a) it were both a professional service and a diagnostic imaging service; and

(b) there were an item in the diagnostic imaging services table that:

(i) related to the service; and

(ii) specified for the service a fee in relation to each State, being the fee specified in the Schedule in relation to the service.

6. Bulk-billing—magnetic resonance imaging

Clause 1.2.10 of the diagnostic imaging services table shall have effect as if an item in Schedule 1 of this Determination were specified in paragraph 1.2.10(1)(a) of the diagnostic imaging services table.

7. Application of items 63454 and 63460

(1) For any particular patient, items 63454 and 63460 apply to a service performed:

(a) in a permissible circumstance; and

(b) using:

(i) eligible equipment; or

(ii) partial eligible equipment.

(2) For any particular patient, a request for items 63454 and 63460 must be:

(a) made in writing; and

(b) identify the clinical indications for the service.

(3) For the purposes of paragraph 7(1)(a), a service is performed in a permissible circumstance only if it is:

(a) both:

(i) performed under the supervision of an eligible provider who is available to monitor and influence the conduct and diagnostic quality of the examination, including, if necessary, by personal attendance on the patient; and

(ii) reported by an eligible provider; or

(b) performed in an emergency; or

(c) performed because of medical necessity, in a remote location.

8. Application of items 63545 and 63546

(1) For any particular patient, items 63545 and 63546 apply to a service performed: (a) at the request of a specialist or consultant physician in accordance with subsection 8(2); and (b) in a permissible circumstance; and (c) using: (i) eligible equipment; or (ii) partial eligible equipment. (2) For any particular patient, a request for items 63545 and 63546 must be: (a) made in writing; and (b) identify the clinical indications for the service. (3) For the purposes of paragraph 8(1)(b), a service is performed in a permissible circumstance only if it is: (a) both: (i) performed under the supervision of an eligible provider who is available to monitor and influence the conduct and diagnostic quality of the examination, including, if necessary, by personal attendance on the patient; and (ii) reported by an eligible provider; or (b) performed in an emergency; or (c) performed because of medical necessity, in a remote location.

9. Application of contrast

(1) An item in the Determination including the symbol (Contrast) applies in addition to: (a) Item 63491 of the diagnostic imaging services table, if the service to which items 63454 or 63460 applies is performed using a contrast agent; or (b) Item 63496 of the Determination, if the service to which items 63545 or 63546 applies is performed using a hepatobiliary-specific contrast agent; or (c) Item 63491 of the diagnostic imaging services table, if the service to which items 63545 or 63546 applies is: (i) performed using an extracellular contrast agent; and (ii) the requesting practitioner indicates the need for imaging with an extracellular contrast agent.

Schedule 1 – relevant services

Part 1 – MRI obstetric services for suspected fetal central nervous system abnormality

<table cellspacing="0" cellpadding="0" style="width:438.65pt; border-collapse:collapse"><thead><tr><td colspan="3" style="width:427.95pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Group I5 – Magnetic Resonance Imaging</span></p></td></tr><tr><td colspan="3" style="width:427.95pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Subgroup 19 – Scan of Body – for specified conditions</span></p></td></tr><tr style="height:16.15pt"><td style="width:57.1pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Item</span></p></td><td style="width:274.45pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Service</span></p></td><td style="width:75pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold"></span><span style="font-size:10pt; font-weight:bold">Fee ($)</span></p></td></tr></thead><tbody><tr style="height:84.85pt"><td style="width:57.1pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>63454</span></p></td><td style="width:274.45pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>MRI – scan of the pelvis or abdomen, if:</span></p><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(a)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the pregnancy is on, or after, 18 weeks gestation; and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(b)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">fetal central nervous system abnormality is suspected; and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(c)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">a</span><span style="font-size:10pt">n ultrasound has been performed and is</span><span style="font-size:10pt"> provided by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics</span><span style="font-size:10pt">,</span><span style="font-size:10pt"> and diagnosis is indeterminate or requires further examination;</span><span style="font-size:10pt"> and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(d)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the service is requested by a specialist practising in the specialty of obstetrics.</span></p></div><p style="font-size:10pt; background-color:#ffffff"><span></span><span>(R) (K) (Anaes.) (Contrast)</span></p></td><td style="width:75pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-left:29.7pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>1200.00</span></p></td></tr><tr style="height:84.25pt"><td style="width:57.1pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>63460</span></p></td><td style="width:274.45pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>MRI – scan of the pelvis or abdomen, if:</span></p><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(a)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the pregnancy is on, or after, 18 weeks gestation; and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(b)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">fetal central nervous system abnormality is suspected; and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(c)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">a</span><span style="font-size:10pt">n </span><span style="font-size:10pt">ultrasound</span><span style="font-size:10pt"> has been performed and is provided </span><span style="font-size:10pt">by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics, and diagnosis is indeterminate or requires further examination</span><span style="font-size:10pt">;</span><span style="font-size:10pt"> and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(d)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the service is requested by a specialist practising in the specialty of obstetrics.</span></p></div><p style="font-size:10pt; background-color:#ffffff"><span></span><span>(R) (NK) (Anaes.) (Contrast)</span></p></td><td style="width:75pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-left:29.7pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>600.00</span></p></td></tr></tbody></table>

Part 2 – MRI services for colorectal or hepatocellular carcinomas

<table cellspacing="0" cellpadding="0" style="width:438.65pt; border-collapse:collapse"><thead><tr><td colspan="3" style="width:427.95pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Group I5 </span><span style="font-size:10pt; font-weight:bold">–</span><span style="font-size:10pt; font-weight:bold"> Magnetic Resonance Imaging</span></p></td></tr><tr><td colspan="3" style="width:427.95pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Subgroup 21 – Scan of Body – for specified conditions</span></p></td></tr><tr><td style="width:57.1pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Item</span></p></td><td style="width:274.45pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Service</span></p></td><td style="width:75pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Fee ($)</span></p></td></tr></thead><tbody><tr style="height:84.85pt"><td style="width:57.1pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>63545</span></p></td><td style="width:274.45pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p class="tabletext" style="margin-top:3pt; margin-bottom:3pt; font-size:10pt; background-color:#ffffff"><span>MRI – multiphase scans of the liver</span><span> (including delayed imaging, if performed)</span><span> with a </span><span>contrast agent, </span><span>for characterisation or intervention planning</span><span>, in a patient with:</span></p><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(a)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>known colorectal carcinoma; and</span></p></div><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(b)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>known, suspected, or possible liver metastasis; and</span></p></div><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(c)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>c</span><span>omputed tomography or ultrasound imaging have identified a mass lesion in the liver</span><span>.</span></p></div><p class="tabletext" style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; background-color:#ffffff"><span>For</span><span> </span><span>any particular patient—</span><span>applicable not more than once in a 12 month period</span><span> (R) (K) (Anaes.)</span><span> (Contrast)</span></p></td><td style="width:75pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-left:29.7pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>550.00</span></p></td></tr><tr style="height:84.25pt"><td style="width:57.1pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>63546</span></p></td><td style="width:274.45pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p class="tabletext" style="margin-top:3pt; margin-bottom:3pt; font-size:10pt; background-color:#ffffff"><span>MRI – multiphase scans of the liver</span><span> (including delayed imaging, if performed)</span><span> with a </span><span>contrast agent, </span><span>for </span><span>diagnosis or staging, in a patient with known or suspected hepatocellular carcinoma, and:</span></p><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(a)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>chronic liver disease</span><span>,</span><span> that </span><span>has been</span><span> confirmed by a specialist</span><span> or consultant physician; and</span></p></div><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(b)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>liver function identified as </span><span>Child-Pugh class A or B</span><span>; and</span></p></div><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(c)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>an </span><span>identified hepatic lesion over 10</span><span> mm in diameter.</span></p></div><p class="tabletext" style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; background-color:#ffffff"><span>For</span><span> </span><span>any particular patient—</span><span>applicable not more than once in a 12 month period</span><span> (R) (K) (Anaes.)</span><span> (Contrast)</span></p></td><td style="width:75pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-left:29.7pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>550.00</span></p></td></tr></tbody></table>

Part 3 – Hepatobiliary-specific contrast agent services

<table cellspacing="0" cellpadding="0" style="width:439.45pt; margin-right:9pt; margin-left:9pt; border-collapse:collapse; float:left"><tbody><tr><td colspan="3" style="width:428.65pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Group I5 – Magnetic Resonance Imaging</span></p></td></tr><tr style="height:11.6pt"><td colspan="3" style="width:428.65pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Subgroup 22 – Modifying items</span></p></td></tr><tr><td style="width:60.1pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Item</span></p></td><td style="width:315.45pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Service</span></p></td><td style="width:31.5pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Fee</span></p></td></tr><tr><td style="width:60.1pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>63496</span></p></td><td style="width:315.45pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; margin-bottom:3pt; page-break-inside:avoid; font-size:10pt"><span>MRI service to which an item in 63545 or 63546 applies if:</span></p><p style="margin-left:36pt; text-indent:-18pt; page-break-inside:avoid; line-height:13pt"><span style="font-size:10pt"><span>a)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the service is performed under the supervision of an eligible provider; and</span></p><p style="margin-left:36pt; text-indent:-18pt; page-break-inside:avoid; line-height:13pt"><span style="font-size:10pt"><span>b)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the service is performed on a person using a hepatobiliary-specific contrast agent.</span></p></td><td style="width:31.5pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:11pt; page-break-inside:avoid; page-break-after:avoid; line-height:13pt"><span style="font-size:10pt">250.00</span></p></td></tr></tbody></table>

Part 1 – MRI obstetric services for suspected fetal central nervous system abnormality

<table cellspacing="0" cellpadding="0" style="width:438.65pt; border-collapse:collapse"><thead><tr><td colspan="3" style="width:427.95pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Group I5 – Magnetic Resonance Imaging</span></p></td></tr><tr><td colspan="3" style="width:427.95pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Subgroup 19 – Scan of Body – for specified conditions</span></p></td></tr><tr style="height:16.15pt"><td style="width:57.1pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Item</span></p></td><td style="width:274.45pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Service</span></p></td><td style="width:75pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold"></span><span style="font-size:10pt; font-weight:bold">Fee ($)</span></p></td></tr></thead><tbody><tr style="height:84.85pt"><td style="width:57.1pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>63454</span></p></td><td style="width:274.45pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>MRI – scan of the pelvis or abdomen, if:</span></p><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(a)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the pregnancy is on, or after, 18 weeks gestation; and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(b)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">fetal central nervous system abnormality is suspected; and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(c)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">a</span><span style="font-size:10pt">n ultrasound has been performed and is</span><span style="font-size:10pt"> provided by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics</span><span style="font-size:10pt">,</span><span style="font-size:10pt"> and diagnosis is indeterminate or requires further examination;</span><span style="font-size:10pt"> and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(d)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the service is requested by a specialist practising in the specialty of obstetrics.</span></p></div><p style="font-size:10pt; background-color:#ffffff"><span></span><span>(R) (K) (Anaes.) (Contrast)</span></p></td><td style="width:75pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-left:29.7pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>1200.00</span></p></td></tr><tr style="height:84.25pt"><td style="width:57.1pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>63460</span></p></td><td style="width:274.45pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>MRI – scan of the pelvis or abdomen, if:</span></p><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(a)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the pregnancy is on, or after, 18 weeks gestation; and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(b)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">fetal central nervous system abnormality is suspected; and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(c)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">a</span><span style="font-size:10pt">n </span><span style="font-size:10pt">ultrasound</span><span style="font-size:10pt"> has been performed and is provided </span><span style="font-size:10pt">by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics, and diagnosis is indeterminate or requires further examination</span><span style="font-size:10pt">;</span><span style="font-size:10pt"> and</span></p></div><div style="margin-left:18pt; background-color:#ffffff"><p style="margin-left:18pt; text-indent:-18pt; line-height:13pt"><span style="font-size:10pt"><span>(d)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the service is requested by a specialist practising in the specialty of obstetrics.</span></p></div><p style="font-size:10pt; background-color:#ffffff"><span></span><span>(R) (NK) (Anaes.) (Contrast)</span></p></td><td style="width:75pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-left:29.7pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>600.00</span></p></td></tr></tbody></table>

Part 2 – MRI services for colorectal or hepatocellular carcinomas

<table cellspacing="0" cellpadding="0" style="width:438.65pt; border-collapse:collapse"><thead><tr><td colspan="3" style="width:427.95pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Group I5 </span><span style="font-size:10pt; font-weight:bold">–</span><span style="font-size:10pt; font-weight:bold"> Magnetic Resonance Imaging</span></p></td></tr><tr><td colspan="3" style="width:427.95pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Subgroup 21 – Scan of Body – for specified conditions</span></p></td></tr><tr><td style="width:57.1pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Item</span></p></td><td style="width:274.45pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Service</span></p></td><td style="width:75pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Fee ($)</span></p></td></tr></thead><tbody><tr style="height:84.85pt"><td style="width:57.1pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>63545</span></p></td><td style="width:274.45pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p class="tabletext" style="margin-top:3pt; margin-bottom:3pt; font-size:10pt; background-color:#ffffff"><span>MRI – multiphase scans of the liver</span><span> (including delayed imaging, if performed)</span><span> with a </span><span>contrast agent, </span><span>for characterisation or intervention planning</span><span>, in a patient with:</span></p><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(a)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>known colorectal carcinoma; and</span></p></div><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(b)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>known, suspected, or possible liver metastasis; and</span></p></div><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(c)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>c</span><span>omputed tomography or ultrasound imaging have identified a mass lesion in the liver</span><span>.</span></p></div><p class="tabletext" style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; background-color:#ffffff"><span>For</span><span> </span><span>any particular patient—</span><span>applicable not more than once in a 12 month period</span><span> (R) (K) (Anaes.)</span><span> (Contrast)</span></p></td><td style="width:75pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-left:29.7pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>550.00</span></p></td></tr><tr style="height:84.25pt"><td style="width:57.1pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>63546</span></p></td><td style="width:274.45pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p class="tabletext" style="margin-top:3pt; margin-bottom:3pt; font-size:10pt; background-color:#ffffff"><span>MRI – multiphase scans of the liver</span><span> (including delayed imaging, if performed)</span><span> with a </span><span>contrast agent, </span><span>for </span><span>diagnosis or staging, in a patient with known or suspected hepatocellular carcinoma, and:</span></p><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(a)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>chronic liver disease</span><span>,</span><span> that </span><span>has been</span><span> confirmed by a specialist</span><span> or consultant physician; and</span></p></div><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(b)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>liver function identified as </span><span>Child-Pugh class A or B</span><span>; and</span></p></div><div style="margin-left:3.75pt; background-color:#ffffff"><p class="tabletext" style="margin-top:0pt; margin-left:21.25pt; margin-bottom:0pt; text-indent:-21.25pt; font-size:10pt"><span><span>(c)</span></span><span style="font:7pt 'Times New Roman'"> </span><span>an </span><span>identified hepatic lesion over 10</span><span> mm in diameter.</span></p></div><p class="tabletext" style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; background-color:#ffffff"><span>For</span><span> </span><span>any particular patient—</span><span>applicable not more than once in a 12 month period</span><span> (R) (K) (Anaes.)</span><span> (Contrast)</span></p></td><td style="width:75pt; border-top:0.75pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.35pt; padding-left:5.35pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; margin-left:29.7pt; margin-bottom:3pt; page-break-after:avoid; line-height:115%; font-size:10pt"><span>550.00</span></p></td></tr></tbody></table>

Part 3 – Hepatobiliary-specific contrast agent services

<table cellspacing="0" cellpadding="0" style="width:439.45pt; margin-right:9pt; margin-left:9pt; border-collapse:collapse; float:left"><tbody><tr><td colspan="3" style="width:428.65pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top; background-color:#ffffff"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Group I5 – Magnetic Resonance Imaging</span></p></td></tr><tr style="height:11.6pt"><td colspan="3" style="width:428.65pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Subgroup 22 – Modifying items</span></p></td></tr><tr><td style="width:60.1pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Item</span></p></td><td style="width:315.45pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Service</span></p></td><td style="width:31.5pt; border-top:1.5pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; page-break-after:avoid; line-height:12pt"><span style="font-size:10pt; font-weight:bold">Fee</span></p></td></tr><tr><td style="width:60.1pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; margin-bottom:3pt; line-height:115%; font-size:10pt"><span>63496</span></p></td><td style="width:315.45pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:3pt; margin-bottom:3pt; page-break-inside:avoid; font-size:10pt"><span>MRI service to which an item in 63545 or 63546 applies if:</span></p><p style="margin-left:36pt; text-indent:-18pt; page-break-inside:avoid; line-height:13pt"><span style="font-size:10pt"><span>a)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the service is performed under the supervision of an eligible provider; and</span></p><p style="margin-left:36pt; text-indent:-18pt; page-break-inside:avoid; line-height:13pt"><span style="font-size:10pt"><span>b)</span></span><span style="font:7pt 'Times New Roman'"> </span><span style="font-size:10pt">the service is performed on a person using a hepatobiliary-specific contrast agent.</span></p></td><td style="width:31.5pt; border-top:1.5pt solid #000000; border-bottom:1.5pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p style="margin-top:11pt; page-break-inside:avoid; page-break-after:avoid; line-height:13pt"><span style="font-size:10pt">250.00</span></p></td></tr></tbody></table>